LONE TREE, Colo., Jan. 8, 2026 /PRNewswire/ -- Cochlear, the global leader in implantable hearing solutions, is proud to announce that the groundbreaking Nucleus® Nexa® System is now available to ...
LONE TREE, Colo., July 8, 2025 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, today announced the U.S Food and Drug Administration (FDA) approval of ...
Cochlear Ltd. heard good news from the U.S. FDA, as the agency approved its next-generation cochlear implant, the Nucleus Nexa System, the first smart cochlear implant system. Cochlear expects to ...
News-Medical.Net on MSN
Toddler thrives after receiving newly FDA-approved cochlear implant system
Six months after becoming the first patient in the United States to receive a newly FDA-approved cochlear implant system, ...
The Cochlear Ltd (ASX: COH) share price is in focus today after the hearing implant leader posted a modest 1% lift in sales revenue to $1,176 million for the half year ended December 2025, but ...
Monday - Friday, 10:00 - 11:00 SIN/HK | 0400 - 05:00 CET In this video Dig Howitt, the CEO of Cochlear, also talks about how the company navigates tariff and supply chain issues, and the new Nucleus ...
Capital Brief on MSN
Cochlear sinks after Nexa rollout hits half-year profit
More news: Shares in Cochlear plunged in early trade after the company reported a 21% fall in statutory net profit. The rollout of its Nucleus Nexa system took longer than expected and weighed on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results